Company: NIVFW
Filing Date: 2025-09-18
Form Type: F-1
Source: 0001213900-25-088927
Chunk: 115

Company: NewGenIvf Group Ltd
Filing Date: 2025-09-18
Form: F-1
Chunk 115
---
able and may be substantially less than the maximum amounts
set forth on the cover page of this prospectus.

We intend to use the net proceeds
of this offering as follows, and we have ordered the specific uses of proceeds in order of priority.

| Description                                    
 of Use                                         |     | Estimated Amount of 
 Net Proceeds        
 (in millions)       |      |
|:-----------------------------------------------|:----|:--------------------|-----:|
| Investments in SOL                             |     | $                   |  5.0 |
| Working capital and general corporate purposes |     | $                   |  8.7 |
| Total                                          |     | $                   | 13.7 |

<div align='center'>DIVIDEND POLICY</div>

We have not declared or paid
any cash dividend on our Class A Ordinary Shares as of the date of this prospectus. We currently intend to retain any future earnings
and do not expect to pay any dividends in the near future. Any further determination to pay dividends on our ordinary shares would be
at the discretion of our Board of Directors, subject to applicable laws, and would depend on our financial condition, results of operations,
capital requirements, general business conditions, and other factors that our Board of Directors may deem relevant.

<div align='center'>65

CAPITALIZATION AND INDEBTEDNESS</div>

Below is the Company’s
capitalization and indebtedness as of December 31, 2024:

| ● | on an actual basis; and |

| ● | on an as adjusted basis to reflect the issuance of up to  4,975,124 Class A Ordinary Shares”) and warrants to purchase up to 2,487,562 of our Class A Ordinary Shares at an assumed offering price of $2.01 per Class A Ordinary Shares, which is the Company’s last reported closing price of our Class A Ordinary Shares on September 15, 2025. |

The as adjusted information
set forth in the following table is illustrative only and will be adjusted based on the actual offering price, which may be lower than
the assumed price and may be at a discount to the market price. You should read this table together with our consolidated financial statements
and the related notes included elsewhere in this prospectus and the information under “Management’s Discussion and Analysis
of Financial Condition and Results of Operations.”

|                            |     | Actual |            |   |     | As Adjusted 
 without     
 Warrant     
 Exercised   |           |   |